NK cell proliferation induced by IL-15 transpresentation is negatively regulated by inhibitory receptors

Journal of Immunology

Volumn 195, Issue 10, 2015, Pages 4810-4821

  Anton, Olga M ^a   Vielkind, Susina ^a   Peterson, Mary E ^a   Tagaya, Yutaka ^b   Long, Eric O ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; HLA ANTIGEN CLASS 1; HLA C ANTIGEN; HLA E ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; PROTEIN KINASE B; RIBOSOME PROTEIN; STAT5 PROTEIN; IL15 PROTEIN, HUMAN; IL15RA PROTEIN, HUMAN; IL2RB PROTEIN, HUMAN; INTERLEUKIN 15 RECEPTOR; KIR2DL1 PROTEIN, HUMAN; KIR2DL2 PROTEIN, HUMAN; KIR2DL3 PROTEIN, HUMAN; KLRD1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY D;

ARTICLE; CELL CONTACT; CELL METABOLISM; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOLECULAR INTERACTION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SYNAPSE; TRANSPRESENTATION; CELL PROLIFERATION; CYTOLOGY; FEMALE; IMMUNOLOGY; MALE; PHOSPHORYLATION; PHYSIOLOGY;

CELL PROLIFERATION; FEMALE; HLA-C ANTIGENS; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; KILLER CELLS, NATURAL; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, INTERLEUKIN-15; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL2; RECEPTORS, KIR2DL3;

EID: 84958664560     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500414     Document Type: Article

References (53)

1. Caligiuri, M. A. 2008. Human natural killer cells. Blood 112: 461-469.
2. Rochman, Y., R. Spolski, and W. J. Leonard. 2009. New insights into the regulation of T cells by gc family cytokines. Nat. Rev. Immunol. 9: 480-490.
3. DiSanto, J. P., W. Müller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor g chain. Proc. Natl. Acad. Sci. USA 92: 377-381.
4. Kawamura, T., R. Koka, A. Ma, and V. Kumar. 2003. Differential roles for IL-15R a-chain in NK cell development and Ly-49 induction. J. Immunol. 171: 5085-5090.
5. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191: 771-780.
6. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9: 669-676.
7. Suzuki, H., G. S. Duncan, H. Takimoto, and T. W. Mak. 1997. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor b chain. J. Exp. Med. 185: 499-505.
8. Vosshenrich, C. A., T. Ranson, S. I. Samson, E. Corcuff, F. Colucci, E. E. Rosmaraki, and J. P. Di Santo. 2005. Roles for common cytokine receptor g-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J. Immunol. 174: 1213-1221.
9. Nosaka, T., J. M. van Deursen, R. A. Tripp, W. E. Thierfelder, B. A. Witthuhn, A. P. McMickle, P. C. Doherty, G. C. Grosveld, and J. N. Ihle. 1995. Defective lymphoid development in mice lacking Jak3. Science 270: 800-802.
10. Park, S. Y., K. Saijo, T. Takahashi, M. Osawa, H. Arase, N. Hirayama, K. Miyake, H. Nakauchi, T. Shirasawa, and T. Saito. 1995. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3: 771-782.
11. Imada, K., E. T. Bloom, H. Nakajima, J. A. Horvath-Arcidiacono, G. B. Udy, H. W. Davey, and W. J. Leonard. 1998. Stat5b is essential for natural killer cellmediated proliferation and cytolytic activity. J. Exp. Med. 188: 2067-2074.
12. Dubois, S., J. Mariner, T. A. Waldmann, and Y. Tagaya. 2002. IL-15Ra recycles and presents IL-15 in trans to neighboring cells. Immunity 17: 537-547.
13. Koka, R., P. R. Burkett, M. Chien, S. Chai, F. Chan, J. P. Lodolce, D. L. Boone, and A. Ma. 2003. Interleukin (IL)-15Ra-deficient natural killer cells survive in normal but not IL-15Ra-deficient mice. J. Exp. Med. 197: 977-984.
14. Burkett, P. R., R. Koka, M. Chien, S. Chai, D. L. Boone, and A. Ma. 2004. Coordinate expression and trans presentation of interleukin (IL)-15Ra and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J. Exp. Med. 200: 825-834.
15. Doherty, T. M., R. A. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156: 735-741.
16. Ogasawara, K., S. Hida, N. Azimi, Y. Tagaya, T. Sato, T. Yokochi-Fukuda, T. A. Waldmann, T. Taniguchi, and S. Taki. 1998. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391: 700-703.
17. Ma, A., R. Koka, and P. Burkett. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24: 657-679.
18. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9: 503-510.
19. Hochweller, K., J. Striegler, G. J. Hämmerling, and N. Garbi. 2008. A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells. Eur. J. Immunol. 38: 2776-2783.
20. Koka, R., P. Burkett, M. Chien, S. Chai, D. L. Boone, and A. Ma. 2004. Cutting edge: murine dendritic cells require IL-15Ra to prime NK cells. J. Immunol. 173: 3594-3598.
21. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517.
22. Schleicher, U., J. Liese, I. Knippertz, C. Kurzmann, A. Hesse, A. Heit, J. A. Fischer, S. Weiss, U. Kalinke, S. Kunz, and C. Bogdan. 2007. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J. Exp. Med. 204: 893-906.
23. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Münz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195: 343-351.
24. Bryceson, Y. T., M. E. March, H. G. Ljunggren, and E. O. Long. 2006. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214: 73-91.
25. Kärre, K. 2008. Natural killer cell recognition of missing self. Nat. Immunol. 9: 477-480.
26. Long, E. O. 2008. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 224: 70-84.
27. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J. P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4: 77-85.
28. Peterson, M. E., and E. O. Long. 2008. Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity 29: 578-588.
29. Liu, D., M. E. Peterson, and E. O. Long. 2012. The adaptor protein Crk controls activation and inhibition of natural killer cells. Immunity 36: 600-611.
30. Castillo, E. F., and K. S. Schluns. 2012. Regulating the immune system via IL-15 transpresentation. Cytokine 59: 479-490.
31. Sato, N., H. J. Patel, T. A. Waldmann, and Y. Tagaya. 2007. The IL-15/IL-15Ra on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. Proc. Natl. Acad. Sci. USA 104: 588-593.
32. Robertson, M. J., K. J. Cochran, C. Cameron, J. M. Le, R. Tantravahi, and J. Ritz. 1996. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24: 406-415.
33. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J. Immunol. 142: 3320-3328.
34. Cohen, G. B., R. T. Gandhi, D. M. Davis, O. Mandelboim, B. K. Chen, J. L. Strominger, and D. Baltimore. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661-671.
35. Stebbins, C. C., C. Watzl, D. D. Billadeau, P. J. Leibson, D. N. Burshtyn, and E. O. Long. 2003. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol. Cell. Biol. 23: 6291-6299.
36. Lee, N., M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. López-Botet, and D. E. Geraghty. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95: 5199-5204.
37. Burshtyn, D. N., J. Shin, C. Stebbins, and E. O. Long. 2000. Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Curr. Biol. 10: 777-780.
38. Wagtmann, N., S. Rajagopalan, C. C. Winter, M. Peruzzi, and E. O. Long. 1995. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3: 801-809.
39. Biassoni, R., C. Cantoni, M. Falco, S. Verdiani, C. Bottino, M. Vitale, R. Conte, A. Poggi, A. Moretta, and L. Moretta. 1996. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183: 645-650.
40. Wagtmann, N., R. Biassoni, C. Cantoni, S. Verdiani, M. S. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, and E. O. Long. 1995. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 2: 439-449.
41. Saleiro, D., and L. C. Platanias. 2015. Intersection of mTOR and STAT signaling in immunity. Trends Immunol. 36: 21-29.
42. Tripathi, P., S. Kurtulus, S. Wojciechowski, A. Sholl, K. Hoebe, S. C. Morris, F. D. Finkelman, H. L. Grimes, and D. A. Hildeman. 2010. STAT5 is critical to maintain effector CD8+ T cell responses. J. Immunol. 185: 2116-2124.
43. Hand, T. W., W. Cui, Y. W. Jung, E. Sefik, N. S. Joshi, A. Chandele, Y. Liu, and S. M. Kaech. 2010. Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc. Natl. Acad. Sci. USA 107: 16601-16606.
44. Brilot, F., T. Strowig, S. M. Roberts, F. Arrey, and C. Münz. 2007. NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Ralpha. J. Clin. Invest. 117: 3316-3329.
45. Long, E. O., H. S. Kim, D. Liu, M. E. Peterson, and S. Rajagopalan. 2013. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 31: 227-258.
46. Barreira da Silva, R., C. Graf, and C. Münz. 2011. Cytoskeletal stabilization of inhibitory interactions in immunologic synapses of mature human dendritic cells with natural killer cells. Blood 118: 6487-6498.
47. Liu, D., T. Meckel, and E. O. Long. 2010. Distinct role of Rab27a in granule movement at the plasma membrane and in the cytosol of NK cells. PLoS One 5: e12870.
48. Schleinitz, N., M. E. March, and E. O. Long. 2008. Recruitment of activation receptors at inhibitory NK cell immune synapses. PLoS One 3: e3278.
49. Imada, K., and W. J. Leonard. 2000. The Jak-STAT pathway. Mol. Immunol. 37: 1-11.
50. Ruvinsky, I., and O. Meyuhas. 2006. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem. Sci. 31: 342-348.
51. Marcais, A., J. Cherfils-Vicini, C. Viant, S. Degouve, S. Viel, A. Fenis, J. Rabilloud, K. Mayol, A. Tavares, J. Bienvenu, et al. 2014. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15: 749-757.
52. Klingmüller, U., U. Lorenz, L. C. Cantley, B. G. Neel, and H. F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80: 729-738.
53. Elpek, K. G., M. P. Rubinstein, A. Bellemare-Pelletier, A. W. Goldrath, and S. J. Turley. 2010. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes. Proc. Natl. Acad. Sci. USA 107: 21647-21652.